Apologies in advance for the long post... click Next if you

New Post Public Reply Private Reply Replies (2) Message Board
Warp Daveludlow #6219
Apologies in advance for the long post... click Next if you don't want to waste the next 2 minutes of your life. LOL

Dave, the dilution concern you continue to refer to as legitimate is obviously not shared by the majority on this board. We are not the naive investors as you think we are. But your concerns over this issue are starting to sound like the rants of those who believe the moon landings were faked, and are frustrated they can't convince everyone else of the truth of this. Seriously, you need to get a grip. Take your concerns to the company, or sell your shares. Most of the naive investors here understand the dilution concern yet we choose to remain invested and keep our focus on the company and the bright outlook of our future.

So your 1.1 million shares represent hard earned money, do they? What the hell do my shares represent? You have no f*cking idea what you're talking about when you make any attempt to characterize me or my investment style. I take my concerns to the source, not to a public message board where others can do little to nothing about it. Gerald has personally addressed every one of my concerns, and in some cases stated the company would be addressing those concerns in the near future, which they have. I'm satisfied with that. If that's a passive investor, then I suppose I choose to remain a passive investor vs. claiming to be a LT investor yet fretting and losing sleep over every possible outcome in my investment. I feel management has enough challenges ahead of them without me creating more by constantly reminding them of my own insecurities with my investment decision. As Gerald has stated, they are building a world-class biotech company, and if I can't stand the heat of the kitchen, then I should sell my shares and move on. Good advice, in my opinion.

It is not the CEO's job to manage my investment as you claim. It is management's job to manage the company and bring shareholder value, using their knowledge and experience to manage the science and build the best shareholder value they can based on bringing their assets to market. It is my job to manage my investment. It is my job to decide to stick with this investment or not based on my results and how I view the company being managed. It is not my job to try to manage the company, nor attempt to sway investor sentiment to agree with my opinion and put pressure on management to better manage my investment. They are busy running the company. If I had the qualifications to manage the company, I'd be working for them, not simply buying their shares.

You seem to believe I'm wealthy. Again, your analysis here sucks. What is your definition of wealth? And how do you think I came into the money to buy my large position? I'll tell you how. I worked my ass off for years, working 12-hour rotating shifts, and adding 600+ hours annually of overtime for many years. While others were taking off to spend time with family and friends on weekends and holidays, I was at the nuclear plant working. So I would characterize my investment dollars just as hard earned, if not more so, than those you've put into your investment. So how about less talk of your hard-earned dollars? Most here earned the money they invest. Your dollars are no different than anyone else's here.

I can assure you of this... if I only owned 100K or 500K in AMBS shares, my concern over possible dilution ahead would be no different than it is now. I live in reality, not the fantasy world you suggest. The real world would have investors who wouldn't invest in pre-revenue biotech companies if they were concerned about dilution. In the fantasy world, investors invest in such companies often to counter their life-long tendency to borrow for everything, not save enough for retirement, and pin all of their hopes on striking it rich, which is why they fret over everything that "might" happen with their investment, instead of having more trust in management to do what is best both for shareholders and the company.

Let me tell you how I view God in this environment. I pray for Gerald and his team, and those conducting the research to help those in need. I pray that this investment will work out the way God intends, whatever that may be. And I pray God has my best interests in mind, whether that is to provide me with abundant wealth to help others in need, or to teach me a valuable lesson about what many would consider my foolish investment of my limited resources in a risky company like Amarantus.

So, while you are fretting and flipping out over what might happen, I have faith this will all work out as God intended. Gerald is not God. But I believe he is genuinely a good person and may very well be one of God's instruments to help those suffering from these various afflictions. And if I'm blessed to enjoy some rewards as a shareholder, I will certainly do my part in passing on some of those blessings to others in need, as well as my local church to spread God's ministry. If you think that's a "passive" investor, so be it. I imagine my blood pressure and sleep patterns are a lot better than yours. And my faith this will all work according to God's plan gives me comfort. That doesn't mean I don't bring my concerns to the company. One would be a fool to blindly invest and hope it all works out, but we obviously have different levels of faith in this investment.

I'd rather drink Kool-Aid than whatever brew you're drinking. What I'm drinking isn't causing unnecessary concerns over what might happen down the road. You really should watch a specific episode of Deep Space Nine called "Statistical Probabilities" (season 6, episode 9). It is a prime example of your over-analysis of everything Amarantus, and how a single event can change everything and make all of the analysis moot.

Speaking of maturity, it seems to me most here are calm adults who understand the risks. But some seem to be spoiled brats crying for attention and pissed off that everyone else doesn't share their concerns.

One final point... you should work on your reading skills because your mention of my post regarding one of the callers on the recent business update call is way off.

What you posted:
Quote:
Unlike Warp, I thought the gentleman who pressed Gerald on those 5 questions during the CC was right on!! Warp writes off discussion about concerns as anxious "hand wringing" and the cause of "sleepless nights" that only the poor engage in, who really shouldn't be invested in this type of stock in the first place. I thought the gentleman asking the questions on the CC was respectful, but earnest.
What I posted:
Quote:
I sat here listening to these 5 questions and was scratching my head, particularly the ones asking Gerald to reveal any partnerships or asset sales in the works, and when the company expected to be profitable. It's sad this investor took up so much time on the call where other investors could have asked reasonable questions that Gerald might be able to legally answer.

So you believe a reasonable investor question would be for specifics on upcoming sales of the LymPro and Eltoprazine assets, or when the company will reach profitability based on partnership agreements or asset sales currently in the works? You really see those questions as respectful and ernest? What fantasy world are you living in? There's no way Gerald could answer those questions, and not wind up with SEC fines or removal by the BOD as CEO. Respectful and ernest? What kind of shareholder would even ask those questions? One who is out of his league as an investor here and should stick with investing in mutual funds. I'm surprised you feel these were valid questions that should be asked.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ALINA Residences Celebrates Luxury VERIFIED™ Status Award

Updated Category News Views 25

ALINA Residences: A New Victory in Luxury Living ALINA Residences, located in the heart of Boca Raton, recently snagged the spotlight with its shiny new VERIFIED™ Luxury Residences plaque from Forbes Travel Guide. To most, it might just seem like a piece of metal, but in the world of upscale living, this is a badge of honor. Celebrating Commitment to Service Excellence...

Continue Reading
Pudu Robotics Eyes Robust Growth from New German HQ

Updated Category News Views 51

Pudu Robotics Solidifies European Expansion with New HQ There's a new sheriff in Neuss, Germany, and it's not wearing a cowboy hat—it's stocked with commercial robots. Yep, Pudu Robotics is planting its flag right there, aiming to supercharge its already rapid growth across Europe. From Store Floors to Hospital Halls Pudu's got some serious momentum. We're talking a...

Continue Reading
transcosmos Boosts Supply Chain with AI-Powered Tools

Updated Category News Views 62

No-Nonsense Supply Chain Evolution at transcosmos Take a hard look at the chaos flying around the supply chain arena these days. It's like every time you turn your head, there's a new twist landing folks into deeper complexity. Look, if you thought supply chain management was a snooze of a topic, think again because transcosmos just dialed up the intensity with its...

Continue Reading
GRUNGE Short Film Bridges Past and Present

Updated Category News Views 40

A New Spin on Nostalgia Let's chew the fat on this little number out of Tucson, Arizona. "GRUNGE," a short suspense horror film, is pulling 90s grunge music up by its Doc Martens and hurling it into a world of psychedelic chaos. Set in 1993, this flick isn't just a trip down memory lane. It's a creative whirlwind leveraging the gritty vibe of the grunge scene to wade into...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 69

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Sabey Data Centers Tests HVO to Cut Emissions

Updated Category News Views 29

Exploring New Horizons in Data Center Energy A curious tale is unfolding down in Austin, Texas, folks—one where data centers meet renewable energy in a bid to clean up their act. Sabey Data Centers is giving good old-fashioned diesel the boot in favor of hydrotreated vegetable oil (HVO) for backup power. We're not talking about minor tweaks here; this is about testing...

Continue Reading
Live 3D Navigation Revolutionizes Dental Implant Surgery

Updated Category News Views 87

Changing the Dental Game You think all teeth stuff’s the same old drill? Guess again. Dr. David Salehani over in LA is flipping the whole implant scene like a pancake on Sunday morning. With tech that sounds like it's straight out of a sci-fi flick, he’s using live 3D navigation to place dental implants more accurately than ever. The Tech Behind the Teeth Alright,...

Continue Reading
Decoding the Insurance Agent Hunt in Hot Springs

Updated Category News Views 35

Look Beyond Just Rates When Selecting Your Agent When it comes to picking the right insurance agent in the charming enclave of Hot Springs, AR, it's not just about snagging the lowest rate. Victoria Payne, a seasoned pro from the Victoria Payne Agency, drills down on what actually counts in the HelloNation article she's featured in. It's about more than dollars and cents;...

Continue Reading
SMTC: Thriving with Innovation in EMS Landscape

Updated Category News Views 42

Trailblazing in the Evolving EMS Arena SMTC's latest accolade from Frost & Sullivan isn't just another feather in their cap. It's a testament to how this mid-tier electronics manufacturing services (EMS) player stands head and shoulders above the rest. While other companies are fumbling with supply chain headaches and shifting market demands, these folks are buckling down...

Continue Reading
WHI's Nexus AI Transforms Phone Ordering in Parts Biz

Updated Category News Views 130

Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharmaceutical Analytical Testing: Growth and Innovations Ahead

Updated Category News Views 156

Overview of the Pharmaceutical Analytical Testing Market The pharmaceutical analytical testing market is undergoing remarkable growth, fueled by the increasing complexity in medication development and an insatiable demand for biologics and biosimilars. This sector requires advanced testing to ensure new therapeutics meet safety and efficacy standards while adhering to...

Continue Reading
Navigating Market Challenges: A Fresh Look at Nasdaq's Future

Updated Category News Views 155

Nasdaq's Business Evolution Nasdaq, Inc. (NASDAQ:NDAQ) stands as a prominent global financial services entity that continually adapts to a dynamic marketplace filled with shifting trading volumes and strategic acquisitions. Recently, the company has made noteworthy strides in enhancing its business model and expanding its market influence. Investors and analysts are...

Continue Reading
Exploring the Future of Automotive Active Seat Headrests

Updated Category News Views 178

Understanding the Automotive Active Seat Headrests Market Growth The automotive active seat headrests market is set to expand significantly, with projections suggesting a valuation reaching USD 25.49 billion by 2031. This growth is largely attributed to the increasing consumer focus on vehicle safety and the rising integration of safety technologies in modern automobiles....

Continue Reading
Crown Castle Boosts Investor Confidence with Dividend Increase

Updated Category News Views 184

Crown Castle Announces Enhanced Quarterly Dividend Crown Castle Inc. (NYSE: CCI), a leading provider of shared communications infrastructure, has shared exciting news for its investors. The Board of Directors has declared a quarterly cash dividend amounting to $1.565 per share. This dividend is a testament to Crown Castle's solid financial health and commitment to...

Continue Reading
Diginex's Strategic Acquisition: Enhancing Human Rights Solutions

Updated Category News Views 156

Diginex's Commitment to Enhancing Human Rights in Supply Chains Diginex Limited (NASDAQ: DGNX), a leader in Sustainability RegTech solutions, has made significant strides by announcing a memorandum of understanding to acquire The Remedy Project Limited. This strategic move highlights Diginex's focused effort to strengthen its advisory capabilities regarding human rights...

Continue Reading